Highly purified oligo-His tagged human recombinant α1-AChR in immunogenic in vivo and suitable for T cell stimulation in vitro in experimental and human myasthenia gravis

Journal of Neuroimmunology

Volumn 80, Issue 1-2, 1997, Pages 131-136

  Voltz, Raymond ^a,b   Kamm, Christoph ^a   Padberg, Frank ^a,b   Malotka, Joachim ^a   Kerschensteiner, Martin ^a   Spuler, Simone ^a,b   Tzartos, Socrates ^c   Dornmair, Klaus ^a  

^a MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

Human acetylcholine receptor; Myasthenia gravis; Protein purification; Recombinant protein; T cell lines

Indexed keywords

CHOLINERGIC RECEPTOR; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMATOGRAPHY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; MYASTHENIA GRAVIS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PURIFICATION; RAT; T LYMPHOCYTE;

AFFINITY LABELS; ANIMALS; AUTOANTIBODIES; CELL LINE; FEMALE; HISTIDINE; HUMANS; LYMPHOCYTE ACTIVATION; MYASTHENIA GRAVIS; OLIGONUCLEOTIDE PROBES; RATS; RATS, INBRED LEW; RECEPTORS, CHOLINERGIC; RECOMBINANT PROTEINS; T-LYMPHOCYTES;

EID: 0031442102     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00147-1     Document Type: Article

References (26)

1. Drachman D.B. Myasthenia gravis. N. Engl. J. Med. 330:1994;1797.
2. Engel, A.G., 1994. Acquired autoimmune myasthenia gravis. In: Engel, A.G., Franzini-Armstrong, C. (Eds.), Myology, 2nd ed. McGraw-Hill, New York, pp. 1769-1797.
3. Harcourt G., Batocchi A.-P., Hawke S., Beeson S., Pantic N., Jacobson L., Willcox N., Vincent A., Newsom-Davis J. Detection of α-subunit isoforms in human muscle acetylcholine receptor by specific T cells from a myasthenia gravis patient. Proc. R. Soc. Lond. 254:1993;1.
4. Hawke S., Matsuo H., Nicolle M., Malcharek G., Melms A., Willcox N. Autoimmune T cells in myasthenia gravis: Heterogeneity and potential for specific immunotargeting. Immunol. Today. 17:1996;307.
5. Hengen P.N. Purification of His-tag fusion proteins from Escherichia coli. TIBS. 20:1995;285.
6. Heukeshoven J., Dernick R. Improved silver staining procedure for fast staining in phast system development unit. I. Staining of sodium dodecyl sulfate gels. Electrophoresis. 9:1985;28.
7. Hochuli E., Bannwarth W., Döbeli H., Gentz R., Stüber D. Genetic approach to facilitate purification of recombinant proteins with a novel metal chelate adsorbent. Bio/Technology. 6:1988;1321.
8. Kojima K., Berger T., Lassmann H., Hinze-Selch D., Zhang Y., Gehrmann J., Reske K., Wekerle H., Linington C. Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia. J. Exp. Med. 180:1994;817.
9. Lannes-Viera J., Goudable B., Drexler K., Gehrmann J., Torres-Nagel N., Hunig T., Wekerle H. Encephalitogenic, myelin basic protein-specific T cells froam naive rat thymus: Preferential use of the T cell receptor gene V beta 8.2 and expression of the CD4-CD8 phenotype. Eur. J. Immunol. 25:1995;611.
10. Lennon V.A., Lambert E.H., Leiby K.R., Okarma T.B., Talib S. Recombinant human acetylcholine receptor α-subunit induces experimental autoimmune myasthenia gravis. J. Immunol. 146:1991;2245.
11. Lindstrom J., Shelton D., Fujii Y. Myasthenia gravis. Adv. Immunol. 42:1988;233.
12. Luther M., Schoepfer R., Whiting P., Casey B., Blatt Y., Montal M., Lindstrom J. A muscle acetylcholine receptor is expressed in the human cerebellar medulloblastoma cell line TE671. J. Neurosci. 9:1989;1082.
13. Manfredi A.A., Protti M.P., Wu X.D., Howard J.F., Conti-Tronconi B.M. CD4+ T-epitope repertoire on the human acetylcholine receptor α subunit in severe myasthenia gravis: A study with synthetic peptides. Neurology. 42:1992;1092.
14. Matsuo H., Batocchi A.-P., Hawke S., Nicolle M., Jacobson L., Vincent A., Newsom-Davis J., Willcox N. Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor. J. Immunol. 155:1995;3683.
15. Melms A., Malcharek G., Gern U., Wiethölter H., Müller C.A., Schoepfer R., Lindstrom J. T cells from normal and myasthenic individuals recognize the human acetylcholine receptor: Heterogeneity of antigenic sites on the α-subunit. Ann. Neurol. 31:1992;311.
16. Mulcahy A.F., Beeson D.M.W., Willcox N., Diamond A.G. Presentation of endogenous acetylcholine receptor antigen to a specific CD4+ T-cell line by a transfected B-cell line. Immunology. 86:1995;116.
17. Noda M., Furutani Y., Takahashi H., Toyosato M., Tanabe T., Shimizu S. Cloning and sequence analysis of calf cDNA and human genomic DNA encoding alpha-subunit precursor of muscle acetylcholine receptor. Nature. 305:1983;818.
18. 86 HLA-DRβ dimorphism in autoantigen presentation to human T cells. Proc. Natl. Acad. Sci. USA. 88:1991;7343.
19. Peterson G.L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 83:1977;346.
20. Pette M., Fujita K., Kitze B., Whitaker J.N., Albert E., Kappos L., Wekerle H. Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurology. 40:1990;1770.
21. Protti M.P., Manfredi A.A., Straub C., Wu X., Howard J.F., Conti-Tronconi B.M. Use of synthetic peptides to establish anti-human acetylcholine receptor CD4+ cell lines from myasthenia gravis patients. J. Immunol. 144:1990;1711.
22. Protti M.P., Manfredi A., Horton R.M., Bellone M., Conti-Tronconi B.M. Myasthenia gravis: Recognition of a human autoantigen at the molecular level. Immunol. Today. 14:1993;363.
23. Schönbeck S., Chrestel S., Hohlfeld R. Myasthenia gravis: Prototype of the antireceptor autoimmune diseases. Int. Rev. Neurobiol. 32:1990;175-200.
24. Voltz R., Hohlfeld R., Fateh-Moghadam A., Witt T., Wich M., Reimers C., Siegele B., Wekerle H. Myasthenia gravis: Measurement of anti-AChR autoantibodies using the cell line TE671. Neurology. 41:1991;1836.
25. Wessel D., Flügge U.I. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal. Biochem. 138:1984;141.
26. Willcox N., Baggi F., Batocchi D., Beeson G., Harcourt S., Hawke S., Jacobson L., Matsuo H., Moody A.-M., Nagvekar M., Nicolle M., Ong B., Pantic N., Newsom-Davis J., Vincent A. Approaches for studying the pathogenic T cells in autoimmune patients. Ann. NY Acad. Sci. 681:1993;219.